Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced the launch of the 29th StarBright Dye, StarBright Red 670, and an expansion of its current range with 29 additional highly validated antibodies conjugated to StarBright Blue 700 and StarBright Violet 610 Dyes.
AbbVie agrees to acquire Cerevel Therapeutics for $8.7bn
Share this article AbbVie will gain access to Cerevel’s neuroscience pipeline of multiple clinical-stage and preclinical candidates. Credit: © AbbVie Inc. All rights reserved. AbbVie